|1.||Safe, Stephen: 3 articles (07/2014 - 01/2007)|
|2.||Singh, Mandip: 2 articles (10/2014 - 07/2014)|
|3.||Patel, Apurva R: 2 articles (10/2014 - 07/2014)|
|4.||Chougule, Mahavir: 1 article (10/2014)|
|5.||Francis, Kevin P: 1 article (07/2014)|
|6.||Lim, Ed: 1 article (07/2014)|
|7.||Chougule, Mahavir B: 1 article (07/2014)|
|8.||Shin, Ji-Ae: 1 article (09/2011)|
|9.||Kwon, Ki Han: 1 article (09/2011)|
|10.||Cho, Nam-Pyo: 1 article (09/2011)|
07/01/2014 - "The objective of this study was to formulate tumor homing PEGylated CREKA peptide conjugated theranostic nanoparticles of DIM-C-pPhC6H5 (DIM-P) and investigate in vivo antitumor activity as well as evaluate the targeted efficiency to lung tumors using imaging techniques. "
09/01/2011 - "A series of synthetic C-substituted DIMs (C-DIMs) analogs was developed, including DIM-C-pPhtBu and DIM-C-pPhC6H5, which exhibited better inhibitory activity in cancer cells than DIM. "
10/01/2014 - "Evaluation of tumor targeting pegylated EphA2 peptide coated nanoparticles (ENDDs) of a novel anticancer agent DIM-C-pPhC6H5 (DIM-P) and Docetaxel (DOC) and investigate its antitumor activity and potential for treatment of lung cancer. "
|2.||Lung Neoplasms (Lung Cancer)
|3.||Breast Neoplasms (Breast Cancer)
|2.||1,1- bis(3'- indolyl)- 1- (4- t- butylphenyl)methane